In-depth proteomic characterization of the response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using data-independent acquisition mass spectrometry (DIA-MS)

Documenti analoghi

• Differential effects of RAS mutations on chemoradiotherapy and total neoadjuvant therapy in locally advanced rectal cancer
  di: Erina Haraguchi, et al.
  Pubblicazione: (2025)
• Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer
  di: Sonay K Ozturk, et al.
  Pubblicazione: (2024)
• MRI‐based qualitative, quantitative, and radiomics/deep learning methods for assessing treatment response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
  di: Shuang Chen, et al.
  Pubblicazione: (2026)
• A crustacean neuropeptide spectral library for data‐independent acquisition (DIA) mass spectrometry applications
  di: Lauren Fields, et al.
  Pubblicazione: (2024)
• Phase II study of long‐course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE‐2
  di: Yoshinori Kagawa, et al.
  Pubblicazione: (2024)